Atlas Trials

A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency

Clinical trial NCT02247154 · COMPLETED

Trial details

NCT number
NCT02247154
Sponsor
Bio Products Laboratory
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Primary or Secondary Antibody Deficiency
Start date
1999-04-01
Primary completion
2001-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.